Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage biotech company developing novel therapeutics to prevent cancer and other diseases, announced today the appointment of Willene Brondum as its new Associate Vice President of Regulatory Affairs and Quality Assurance.Continue reading→

There are more than 7,000 known rare diseases, affecting more people than cancer and AIDS combined!  TGen’s Center for Rare Childhood Disorders gives hope and answers to rare disease patients by using genetic testing to find accurate diagnoses and develop effective treatments – at no cost to the family.Continue reading→

The Phoenix City Council voted unanimously to provide seed funding for a technology medical and life science accelerator at the University of Arizona on the Phoenix Biomedical Campus.

Continue reading→

Six Arizona bioscience startup firms have been competitively selected by the Flinn Foundation to participate in its 2018 Bioscience Entrepreneurship Program, receiving $30,000 each in funding support and program services administered through a nonprofit partner.Continue reading→

 Researchers at the University of Arizona College of Medicine – Tucson suggest liquefied brain fluid may be one cause of dementia after stroke.Continue reading→

Legislation will create jobs, grow Arizona businesses in biomedicine, science

“The goal of this bill is to ensure that more dollars continue to go to R&D and job creation and less to unnecessary red tape” ~  Joan Koerber-Walker, President & CEO, AZBioContinue reading→

Study shows first applications of DNA origami for nanomedicine Continue reading→

The Center for Advancing Innovation and MedImmune have partnered to launch the Freedom from Cancer Startup Challenge (FCSC). The FCSC will feature risk mitigated, and commercially viable inventions from leading research organizations. Continue reading→